Published in Curr Drug Targets on May 01, 2014
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med (2008) 3.07
Evaluation of new treatments in radiation oncology: are they better than standard treatments? JAMA (2005) 2.37
Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis (2011) 2.19
Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review. Biol Blood Marrow Transplant (2009) 1.51
Do community health worker interventions improve rates of screening mammography in the United States? A systematic review. Cancer Epidemiol Biomarkers Prev (2011) 1.44
Medical research: Trial unpredictability yields predictable therapy gains. Nature (2013) 1.41
Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: a case study of meta-analyses of multiple myeloma trials. Contemp Clin Trials (2012) 1.40
Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis. Biol Blood Marrow Transplant (2009) 1.40
Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols. J Clin Epidemiol (2012) 1.32
New treatments compared to established treatments in randomized trials. Cochrane Database Syst Rev (2012) 1.28
Bisphosphonates in multiple myeloma: a network meta-analysis. Cochrane Database Syst Rev (2012) 1.16
Adherence to antiretroviral therapy in India: a systematic review and meta-analysis. Indian J Community Med (2013) 1.16
Optimism bias leads to inconclusive results-an empirical study. J Clin Epidemiol (2010) 1.12
Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology. Clin Cancer Res (2008) 1.09
In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein. Amino Acids (2011) 1.08
Identification and in silico analysis of functional SNPs of the BRCA1 gene. Genomics (2007) 1.06
Drug resistance mechanism of PncA in Mycobacterium tuberculosis. J Biomol Struct Dyn (2013) 1.04
Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PLoS One (2013) 1.03
Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Syst Rev (2013) 1.03
Single versus double balloon enteroscopy for small bowel diagnostics: a systematic review and meta-analysis. J Clin Gastroenterol (2015) 1.02
AKT kinase pathway: a leading target in cancer research. ScientificWorldJournal (2013) 1.01
Jejunogastric intussusception presenting with outlet obstruction. Indian J Gastroenterol (2003) 0.97
Poor outcome of patients with myelodysplastic syndrome after azacitidine treatment failure. Clin Lymphoma Myeloma Leuk (2013) 0.96
Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design. Cancer Control (2007) 0.96
Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. J Hematol Oncol (2013) 0.95
Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission. Cochrane Database Syst Rev (2011) 0.94
Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis. Br J Haematol (2013) 0.93
Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma. World J Hepatol (2013) 0.92
Efficacy of adoptive immunotherapy with donor lymphocyte infusion in relapsed lymphoid malignancies. Immunotherapy (2013) 0.92
CEP proteins: the knights of centrosome dynasty. Protoplasma (2013) 0.92
Studies on adaptability of binding residues and flap region of TMC-114 resistance HIV-1 protease mutants. J Biomol Struct Dyn (2011) 0.92
High-risk consumers' perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis. Genet Med (2012) 0.91
How do physicians decide to treat: an empirical evaluation of the threshold model. BMC Med Inform Decis Mak (2014) 0.91
Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis. J Mol Model (2010) 0.90
Impact of Diagnostic Delay and Other Risk Factors on Eosinophilic Esophagitis Phenotype and Esophageal Diameter. J Clin Gastroenterol (2016) 0.90
Investigation on the role of nsSNPs in HNPCC genes--a bioinformatics approach. J Biomed Sci (2009) 0.90
Bisphosphonates in multiple myeloma. Cochrane Database Syst Rev (2010) 0.89
Computational SNP analysis: current approaches and future prospects. Cell Biochem Biophys (2014) 0.89
Evidence of colorectal cancer-associated mutation in MCAK: a computational report. Cell Biochem Biophys (2013) 0.89
Effect of deleterious nsSNP on the HER2 receptor based on stability and binding affinity with herceptin: a computational approach. C R Biol (2008) 0.86
Association between colonic diverticulosis and prevalence of colorectal polyps. Int J Colorectal Dis (2014) 0.84
Identification and structural comparison of deleterious mutations in nsSNPs of ABL1 gene in chronic myeloid leukemia: a bio-informatics study. J Biomed Inform (2007) 0.84
Use and taxonomy of social media in cancer-related research: a systematic review. Am J Public Health (2014) 0.84
Investigation of binding phenomenon of NSP3 and p130Cas mutants and their effect on cell signalling. Cell Biochem Biophys (2013) 0.84
Molecular dynamic simulation reveals damaging impact of RAC1 F28L mutation in the switch I region. PLoS One (2013) 0.83
In silico analysis of structural and functional consequences in p16INK4A by deleterious nsSNPs associated CDKN2A gene in malignant melanoma. Biochimie (2008) 0.82
Mutational analysis of FUS gene and its structural and functional role in amyotrophic lateral sclerosis 6. J Biomol Struct Dyn (2014) 0.82
Matching research design to clinical research questions. Indian J Sex Transm Dis (2012) 0.82
Relationship between a point mutation S97C in CK1δ protein and its affect on ATP-binding affinity. J Biomol Struct Dyn (2013) 0.82
Structural basis for the resilience of Darunavir (TMC114) resistance major flap mutations of HIV-1 protease. Interdiscip Sci (2009) 0.81
In silico prediction of a disease-associated STIL mutant and its affect on the recruitment of centromere protein J (CENPJ). FEBS Open Bio (2012) 0.81
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation. Cochrane Database Syst Rev (2014) 0.81
Exploring the cause of drug resistance by the detrimental missense mutations in KIT receptor: computational approach. Amino Acids (2010) 0.81
Exploring the role of cation-pi interactions in glycoproteins lipid-binding proteins and RNA-binding proteins. J Theor Biol (2007) 0.81
Prioritization of candidate SNPs in colon cancer using bioinformatics tools: an alternative approach for a cancer biologist. Interdiscip Sci (2010) 0.81
Multiple myeloma: detecting the effects of new treatments. Lancet (2008) 0.81
Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis. Haematologica (2009) 0.80
Computational and structural investigation of deleterious functional SNPs in breast cancer BRCA2 gene. Sheng Wu Gong Cheng Xue Bao (2008) 0.80
In-silico screening of cancer associated mutation on PLK1 protein and its structural consequences. J Mol Model (2013) 0.80
Computational investigation of cancer-associated molecular mechanism in Aurora A (S155R) mutation. Cell Biochem Biophys (2013) 0.80
Influence of C-H...pi hydrogen bonds in interleukins. In Silico Biol (2008) 0.79
The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. Cochrane Database Syst Rev (2016) 0.79
Value of repeat head computed tomography after traumatic brain injury: systematic review and meta-analysis. J Neurotrauma (2013) 0.79
Investigations on C-H...pi interactions in RNA binding proteins. Int J Biol Macromol (2007) 0.78
Identifying homogenous subgroups for individual patient meta-analysis based on Rough Set Theory. Conf Proc IEEE Eng Med Biol Soc (2014) 0.78
Identifying therapeutic template by evaluating the structural stability of gram positive anti-bacterial peptides--a computational approach. Interdiscip Sci (2011) 0.78
In silico identification of significant detrimental missense mutations of EGFR and their effect with 4-anilinoquinazoline-based drugs. Appl Biochem Biotechnol (2009) 0.78
A flexible alternative to the Cox proportional hazards model for assessing the prognostic accuracy of hospice patient survival. PLoS One (2012) 0.78
What kind of evidence do patients and practitioners need: evidence profiles based on 5 key evidence-based principles to summarize data on benefits and harms. Cancer Treat Rev (2006) 0.78
Evolution driven structural changes in CENP-E motor domain. Interdiscip Sci (2013) 0.78
Identifying novel oncogenes: a machine learning approach. Interdiscip Sci (2014) 0.77
Analysis of binding residues between scorpion neurotoxins and D2 dopamine receptor: a computational docking study. Comput Biol Med (2008) 0.77
Roadmap to determine the point mutations involved in cardiomyopathy disorder: a Bayesian approach. Gene (2013) 0.77
Exploring the role of C-H....pi interactions on the structural stability of single chain "all-alpha" proteins. Appl Biochem Biotechnol (2009) 0.77
Effect of Gestational Exposure of Cypermethrin on Postnatal Development of Brain Cytochrome P450 2D1 and 3A1 and Neurotransmitter Receptors. Mol Neurobiol (2014) 0.77
Imprinting of cerebral and hepatic cytochrome p450s in rat offsprings exposed prenatally to low doses of cypermethrin. Mol Neurobiol (2013) 0.77
Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance. BMC Med Res Methodol (2011) 0.77
Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence? Br J Haematol (2007) 0.77
A compact review on the comparison of conventional and non-conventional interactions on the structural stability of therapeutic proteins. Interdiscip Sci (2011) 0.76
Computational centrosomics: an approach to understand the dynamic behaviour of centrosome. Gene (2012) 0.76
Exploring the C-H...O interactions in glycoproteins. Appl Biochem Biotechnol (2009) 0.76
Influence of cation-pi interactions on RNA-binding proteins. Int J Biol Macromol (2006) 0.76
Influence of cation-pi interactions to the structural stability of prokaryotic and eukaryotic translation elongation factors. Protoplasma (2009) 0.76
Exploring the structural and functional effect of pRB by significant nsSNP in the coding region of RB1 gene causing retinoblastoma. Sci China Life Sci (2010) 0.76